期刊
BIOSCIENCE TRENDS
卷 13, 期 1, 页码 58-69出版社
IRCA-BSSA
DOI: 10.5582/bst.2019.01003
关键词
Extrahepatic cholangiocarcinoma; PD-L1; TILs; HLA class I molecules; TAMs
类别
资金
- Beijing Municipal Administration of Hospital's Mission Plan [SML20152201]
- Beijing Municipal Administration of Hospital's Clinical Medicine Development of Special Funding Support [ZYLX201712]
Immunotherapy might be an effective treatment in extrahepatic cholangiocarcinoma (eCCA), a tumor with extremely limited therapeutic options. Our study is to characterize the programmed death ligand-1 (PD-L1) protein expression and cancer microenvironment profiles in surgically resected eCCA samples. PD-Ll positivity was observed on tumor cells (32.3%) as well as on tumor-associated macrophages (74.2%). PD-Li expression by eCCA correlated significantly with immune parameters such as intra-tumoral CD3+ tumor infiltrating lymphocytes (TILs) density (P = 0.002), intra-tumoral CD8+ ins density (P < 0.001), and the expression pattern of human leukocyte antigen (HLA) class I (P < 0.001). Immunofluorescence showed that PD-L1 positive tumor cells were adjacent to PD-1 positive cells and the stroma covered with interferon-gamma. Correlation with clinicopathological parameters and survival analyses revealed that PD-Ll positivity in eCCA was related to the absence of venous invasion (P= 0.030), improved overall survival (P= 0.020) and progressionfree survival (P= 0.011). HLA class I molecules defect, which is an important mechanism of immune evasion, was frequently observed in eCCA (50.0%) and was associated with a decreased number of intra-tumoral CD8+ TM density (P= 0.028). Additionally, the presence of unusually high numbers of tumor-associated macrophages (TAMs) subsets M2 in most of eCCA (74.2%) was noted. Our study indicated that PD-Li expression in association with intra-tumoral TILs infiltration and !ILA class I expression in 32.3% of the eCCA reflects an active immune microenvironment potentially responsive to PD-1/PD-L1 inhibitors. In addition, the combination of macrophage-targeting agents may provide therapeutic synergy for future immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据